VMC
59
2
ES
50
3
RF
63
2
RRC
68
-2
V
54
2
LOW
45
2
SIG
52
2
IFF
62
5
FSLR
60
-10
ETN
61
2
NWL
57
3
SWKS
56
8
CMI
73
-2
HOG
38
2
MCD
46
4
D
45
4
ROK
47
-3
TRIP
52
2
KMB
33
2
LNC
70
-2
VMC
59
2
ES
50
3
RF
63
2
RRC
68
-2
V
54
2
LOW
45
2
SIG
52
2
IFF
62
5
FSLR
60
-10
ETN
61
2
NWL
57
3
SWKS
56
8
CMI
73
-2
HOG
38
2
MCD
46
4
D
45
4
ROK
47
-3
TRIP
52
2
KMB
33
2
LNC
70
-2
Financhill
Back

Entheon Biomedical Corp. 10K Form

Buy
57

ENBI.CX
Entheon Biomedical Corp.

Last Price:
$0.10
Seasonality Move:
30.28%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive ENBI.CX News And Ratings

See the #1 stock for the next 7 days that we like better than ENBI.CX

ENBI.CX Financial Statistics

Sales & Book Value

Annual Sales: $0
Cash Flow: $-27.2K
Price / Cash Flow: 0
Annual Sales: $0.03
Price / Book: 3.56

Profitability

EPS (TTM): -0.02980
Net Income (TTM): $-343K
Gross Margin: $0
Return on Equity: -100.93%
Return on Assets: -92.33%

Entheon Biomedical Corp. Earnings Forecast

Key Entheon Biomedical Corp. Financial Ratios

  • The Research & Development expenses have been 0.00% of Revenue.
  • Per Share Earnings over the last 9 years have been positive in 4 years.

Entheon Biomedical Corp. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: CNSX
Current Symbol: ENBI.CX
Website: entheonbiomedical.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 21.88
Quick Ratio: 20.77

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

ENBI.CX Technical Analysis vs Fundamental Analysis

Buy
57
Entheon Biomedical Corp. (ENBI.CX) is a Buy

Is Entheon Biomedical Corp. a Buy or a Sell?